Otolaryngologists agree with their fellow physicians who prescribe drugs-pharmaceutical companies have no business buying or using information on how and when they prescribe particular drugs, nor do they want to be confronted by pharmaceutical company representatives in their office about why they do or don’t prescribe that company’s products.
Avoiding the Operating Room: The Advantages of Office-Based Laryngology and Esophagology
How Standard Is “Standard of Care”?
How much do your treatments and procedures vary from the established standard of care? Does it matter?
When It Comes to Drug Development, What Do Our Dollars Buy?
Two studies look at trends in the cost and length of time spent developing new pharmaceuticals
Distinguished Panel Deliberates Expert Witness Testimony
As medical malpractice lawsuits have become increasingly standard fare in the United States judicial system, providing expert witness testimony has become something of a cottage industry in the medical and scientific communities.
Situation Critical: Otolaryngologists See Diminishing Returns for Taking Emergency Call
Getting out of the Insurance Game
Transitioning to a cash-only practice can increase your income-and your career satisfaction
Louisiana Otolaryngologists Use Ingenuity and Community Spirit to Get Back to Business after Katrina
In late August of 2005, many of us watched from the relative safety of our homes and offices as Hurricane Katrina wrought havoc and devastation all along the Gulf coast.
Multispecialty Collaboration: Learning from Our Past to Shape Our Future
One of the enjoyable aspects of our specialty is the variety of patients and problems we see every day.
Prescription Drug Benefit Primer
This January, the Medicare Prescription Drug Benefit, created by the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA), took effect.